BusinessOak Therapeutics Announces Results of Bioequivalence Study of Company’s Oral Dissolvable Strip for TuberculosisBy Nasdaq OMXOct 3, 2017, 1:00 PM UTC
BusinessCURE Pharmaceutical Launches New Academic Partnership Program Providing the Company’s Proprietary CureFilm™ for More Humane and Effective Animal ResearchBy Nasdaq OMXSep 6, 2017, 1:00 PM UTC
BusinessLeading OTF Manufacturer CURE Pharmaceutical Comments on New Report Showing Exponential Growth in Thin Film Drug Manufacturing MarketBy Nasdaq OMXJun 7, 2017, 3:14 PM UTC
